Hermetica Superfood Encyclopedia
The Short Answer
Ligusticum wallichii is a traditional Chinese medicinal herb containing tetramethylpyrazine as its primary bioactive compound. It works by improving blood circulation through vasodilation and antiplatelet aggregation mechanisms.
CategoryHerbs (Global Traditional)
GroupTraditional Chinese Medicine
Evidence LevelModerate
Primary KeywordLigusticum wallichii benefits
Synergy Pairings3
Ligusticum wallichii — botanical close-up
Health Benefits
Origin & History
Natural habitat
Ligusticum wallichii (Chuanxiong) is a perennial herb from the Apiaceae family native to China, particularly growing in Sichuan and Yunnan provinces. The rhizome and root are harvested as the medicinal source, typically processed through aqueous decoction, ethanol extraction, or isolation of specific compounds like ligustrazine.
“Ligusticum wallichii has been used in Traditional Chinese Medicine for over 1,000 years to invigorate blood circulation, relieve pain, and treat cardiovascular conditions. Historically applied in TCM formulas for headache, menstrual issues, and vascular protection.”Traditional Medicine
Scientific Research
Limited human clinical evidence exists, with one RCT (PMID: 1301850) treating 158 patients with transient ischemic attack showing superiority of Ligusticum wallichii over aspirin. Most evidence comes from preclinical studies, including rat myocardial infarction models (PMC4150451) and bronchial asthma research (PMID: 7841753), with no large-scale RCTs or meta-analyses identified.
Preparation & Dosage
Traditional preparation
Clinical dosing poorly defined; preclinical studies used aqueous extract at 0.2-0.6 g/kg body weight daily in rats, while isolated ligustrazine was studied at >150 mg/kg daily for kidney protection. Human standardized extract dosages not established in available research. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Ligusticum wallichii (Chuanxiong) rhizome contains negligible macronutrients in therapeutic dosing (typically 3–9g dried herb or 1–2g extract). Primary bioactive compounds include: tetramethylpyrazine (ligustrazine) at approximately 0.1–0.5% dry weight — the principal vasoactive alkaloid; ferulic acid at 0.02–0.05% dry weight — a phenolic acid with antioxidant and antiplatelet activity; senkyunolide A and Z-ligustilide (phthalide lactones) comprising roughly 1–5% of volatile oil fraction; and cnidilide and butylidenephthalide as additional phthalides. Polysaccharide content ranges 5–8% dry weight contributing mild immunomodulatory activity. Calcium, potassium, and magnesium are present in trace mineral amounts typical of root herbs but are not clinically significant contributors. Bioavailability note: tetramethylpyrazine demonstrates rapid oral absorption (Tmax ~1 hour) but short half-life (~2–3 hours), necessitating divided dosing; ferulic acid bioavailability is enhanced in aqueous decoctions versus raw powder; Z-ligustilide is volatile and degrades with prolonged high-heat processing.
How It Works
Mechanism of Action
Ligusticum wallichii's primary bioactive compound tetramethylpyrazine inhibits platelet aggregation by blocking calcium channels and reducing thromboxane A2 production. The herb promotes vasodilation through nitric oxide pathway activation and antagonizes vasoconstriction mediated by endothelin-1. Additional phthalide compounds enhance microcirculation by improving red blood cell deformability and reducing blood viscosity.
Clinical Evidence
One randomized controlled trial with 158 participants demonstrated Ligusticum wallichii's 89.2% effectiveness rate for treating transient ischemic attacks, significantly outperforming aspirin's 61.7% rate. Preclinical studies show cardiovascular benefits including improved left ventricular ejection fraction and reduced myocardial infarct size. However, human clinical evidence remains limited with most research conducted in animal models. The available evidence suggests moderate support for cerebrovascular applications but requires larger clinical trials for definitive therapeutic recommendations.
Safety & Interactions
Ligusticum wallichii may increase bleeding risk when combined with anticoagulant medications like warfarin or antiplatelet drugs due to its blood-thinning properties. Common side effects include mild gastrointestinal upset, dizziness, and headache in sensitive individuals. The herb should be avoided during pregnancy and breastfeeding due to insufficient safety data. Patients scheduled for surgery should discontinue use at least two weeks prior to prevent excessive bleeding complications.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Ligusticum wallichiiChuanxiongSzechuan lovageChinese lovageCnidium officinaleChuan xiongLigusticum striatum
Frequently Asked Questions
What is the active compound in Ligusticum wallichii?
The primary active compound is tetramethylpyrazine, which provides antiplatelet and vasodilatory effects. Other bioactive components include phthalides like ligustilide and senkyunolide that enhance circulation.
How effective is Ligusticum wallichii for stroke prevention?
One clinical trial showed 89.2% effectiveness for transient ischemic attacks compared to 61.7% with aspirin. However, more large-scale human studies are needed to confirm stroke prevention benefits.
What is the typical dosage of Ligusticum wallichii?
Traditional Chinese medicine typically uses 3-10 grams of dried root daily in decoctions. Standardized extracts may require different dosing, so consultation with a qualified practitioner is recommended.
Can Ligusticum wallichii interact with blood thinners?
Yes, it can significantly increase bleeding risk when combined with warfarin, aspirin, or other anticoagulants due to its antiplatelet effects. Medical supervision is essential for concurrent use.
Is Ligusticum wallichii safe during pregnancy?
No, it should be avoided during pregnancy and breastfeeding due to insufficient safety data and potential effects on blood circulation. Consult healthcare providers before use in reproductive-age women.
What does the research show about Ligusticum wallichii's effectiveness for transient ischemic attacks?
A randomized controlled trial with 158 participants demonstrated that Ligusticum wallichii achieved a 89.2% effectiveness rate for treating transient ischemic attacks, compared to 61.7% with aspirin alone, suggesting superior outcomes for this cerebrovascular condition. This moderate-quality evidence indicates the herb may offer meaningful benefits for patients experiencing temporary stroke-like symptoms. However, more large-scale studies are needed to confirm these findings and establish optimal protocols for clinical use.
Who benefits most from taking Ligusticum wallichii supplements?
Individuals with a history of cerebrovascular events, including transient ischemic attacks or those seeking cardiovascular support, may benefit most from Ligusticum wallichii supplementation based on current research. People concerned with cardiovascular health following myocardial infarction may also find value, though preclinical evidence for this application remains preliminary. Those with inflammatory conditions related to vascular dysfunction could potentially benefit from its anti-inflammatory properties, though clinical confirmation is still ongoing.
How does Ligusticum wallichii work to protect blood vessels and the brain?
Ligusticum wallichii appears to work through multiple mechanisms, including inhibition of inflammatory markers like IL-1β, which reduces vascular inflammation and protects cerebrovascular tissue. Preclinical studies show it improves left ventricular function and reduces cardiac damage, suggesting effects on both blood vessel and heart tissue. These combined anti-inflammatory and cardioprotective actions may explain its traditional use in Chinese herbal medicine for stroke prevention and cerebral ischemia.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w ligusticum-wallichii curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
